Human FGF basic/FGF2/bFGF Antibody
Bio-Techne includes R&D Systems | Catalog # AB-233-NA

Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Summary for Human FGF basic/FGF2/bFGF Antibody
Immunogen
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human FGF basic/FGF2/bFGF Antibody
Cell Proliferation Induced by FGF basic/FGF2/bFGF and Neutralization by Human FGF basic/FGF2/bFGF Antibody.
Recombinant Human FGF basic/FGF2/bFGF 146 aa (Catalog # 233-FB) stimulates proliferation in the NR6R-3T3 mouse fibroblast cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human FGF basic/FGF2/bFGF 146 aa (0.5 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human FGF basic/FGF2/bFGF Polyclonal Antibody (Catalog # AB-233-NA). The ND50 is typically 0.5-1.0 µg/mL.Applications for Human FGF basic/FGF2/bFGF Antibody
Immunohistochemistry
Sample: Immersion fixed paraffin-embedded sections of human ovarian cancer tissue
Western Blot
Sample: Recombinant Human FGF basic/FGF2/bFGF 157 aa (Catalog # 234-FSE)
Neutralization
Formulation, Preparation, and Storage
Purification
Endotoxin Level
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: FGF basic/FGF2/bFGF
FGF basic is a member of the FGF family of at least 23 related mitogenic proteins which show 35-60% amino acid conservation. FGF acidic and basic, unlike theother members of the family, lack signal peptides and are apparently secreted by mechanisms other than the classical protein secretion pathway. FGF basic hasbeen isolated from a number of sources, including neural tissue, pituitary, adrenal cortex, corpus luteum, and placenta. This factor contains four cysteine residues,but reduced FGF basic retains full biological activity, indicating that disulfide bonds are not required for this activity. A variety of forms of FGF basic are producedas a result of Nterminal extensions. These extensions affect localization of FGF basic in cellular compartments but do not affect biological activity. Binding of FGFto heparin or cell surface heparan sulfate proteoglycans is necessary for binding of FGF to high affinity FGF receptors. FGF acidic and basic appear to bind to thesame high affinity receptors and show a similar range of biological activities. FGF basic stimulates the proliferation of all cells of mesodermal origin and many cellsof neuroectodermal, ectodermal, and endodermal origin. FGF basic induces neuron differentiation, survival, and regeneration. FGF basic also modulates embryonicdevelopment and differentiation. These observed in vitro functions of FGF basic suggest FGF basic may play a role in vivo in the modulation of such normalprocesses as angiogenesis, wound healing and tissue repair, embryonic development and differentiation, and neuronal function and neural degeneration. Additionally,FGF basic may participate in the production of a variety of pathological conditions resulting from excessive cell proliferation and excessive angiogenesis.
References
- Coulier, F. et al. (1997) J. Mol. Evol. 44:43.
- Chen, C.H. et al. (2004) Curr. Vasc. Pharmacol. 2:33.
- Mohammadi, M. et al. (2005) Curr. Opin. Struct. Biol. 15:506.
- Fernig, D. et al. (1994) Prog. Growth Factor Res. 5:353.
Long Name
Alternate Names
Gene Symbol
Additional FGF basic/FGF2/bFGF Products
Product Documents for Human FGF basic/FGF2/bFGF Antibody
Product Specific Notices for Human FGF basic/FGF2/bFGF Antibody
For research use only